<div><div></div><div>DSS entered into a securities purchase agreement with Alset International for a $2.45 million convertible promissory note and warrants. The 3% note is convertible at $0.74 per share before its five-year maturity; the warrants cover 16,554,055 shares at a $0.93 exercise price and expire in five years. Closing is subject to customary conditions, including stockholder approval, and is intended to strengthen liquidity.Agreement details:<ul><li>Agreement type: $2.45 million 3% five-year convertible note with warrants</li><li>Counterparty: Alset International</li><li>Signed / Effective: Mar 26 2026 / same</li><li>Duration / Termination: 5 years</li><li>Reason: Enhance liquidity and fund operations</li></ul>Original SEC Filing: DSS, INC. [ DSS ] - 8-K - Mar. 31, 2026<section>Disclaimer<div>This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.</div></section></div></div>

LABU

SBIO

LABD

DSS has secured a $2.45 million convertible promissory note with Alset International, featuring a 3% interest rate and a five-year maturity. The note is convertible at $0.74 per share, while the accompanying warrants cover 16,554,055 shares at an exercise price of $0.93, expiring in five years. The agreement aims to enhance liquidity and fund operations, pending customary conditions including stockholder approval.

TradingView

Direxion S&P Biotech Bull 3X

Invesco Biotechnology & Genome ETF

ALPS Medical Breakthrough

Alset

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

Direxion S&P Biotech Bear 3X

DSS Secures $2.45 Million 3% Five-Year Convertible Note With Warrants From Alset International